IBB News 230.51 05/14/2014 05:07:09 Nasdaq Biotechnology Ishares

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nasdaq Biotechnology Ishares (IBB) 230.51 $IBB

R.I.P. the Momentum Trade, 2012-2014
at The Street - Tue May 13, 1:39PM CDT
The momentum trade is dead. And a new momentum trade has risen to take its place.

iShares Nasdaq Biotechnology Index Fund (IBB) : Close former position at last price ($232.50)
Trading Central - Tue May 13, 9:10AM CDT
On a relative basis against the IVV S&P500, the iShares Nasdaq Biotechnology Index Fund is losing upward momentum since it is reversing down from a bearish trend line; we prefer to close our long position opened on April 22nd. Trading strategy: ...

Watch for iShares Nasdaq Biotechnology Index to Potentially Pullback After Gaining 2.42% Yesterday
Comtex SmarTrend(R) - Mon May 12, 4:06PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of iShares Nasdaq Biotechnology Index to Potentially Pullback after Yesterday's 2.42% Rise
Comtex SmarTrend(R) - Mon May 12, 4:03PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $227.09 to a high of $232.40. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $231.14 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Growth Correction Over - Real Time Insight
Kevin Cook - Zacks Investment Research - Mon May 12, 2:00PM CDT
Where are you finding GARP now?

Market Bulls Gather for Investors Rotating Portfolios
at The Street - Mon May 12, 12:04PM CDT
Despite all the recent divergences, the market is setting up for a bullish week.

Premier Biomedical Advances Technology via Partnerships
ACCESSWIRE - Fri May 09, 9:28AM CDT
Whitefish, MT / May 9, 2014 / Biotechnology stocks have had a rough quarter, with the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) falling more than 6% since February. Investors have started to re-evaluate the sector's lofty valuations, while higher interest rates in the near future could slow the M&A frenzy. As a result, investors may want to shift their attention to high-growth bargains in the industry.

iShares Nasdaq Biotechnology Index Set to Possibly Rebound After Yesterday's Selloff of 1.82%
Comtex SmarTrend(R) - Thu May 08, 3:50PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.82%, iShares Nasdaq Biotechnology Index Offers Investors Better Value
Comtex SmarTrend(R) - Thu May 08, 3:49PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $222.87 to a high of $231.14. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $223.00 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Bull of the Day: Gilead Sciences (GILD) - Bull of the Day
Kevin Cook - Zacks Investment Research - Mon May 05, 1:49AM CDT
Bull of the Day: Gilead Sciences (GILD) - Bull of the Day

'Fast Money' Recap: The Problem With Growth Stocks
at The Street - Tue Apr 29, 4:00AM CDT
The trading panel wonders why Facebook is having a good quarter when Google has been selling off.

Pharma ETFs: A Safe Haven from the Biotech Stock Slump? - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Mon Apr 28, 10:42AM CDT
Why investors may want to think about a play on the pharmaceutical ETFs if they want drug industry exposure.

iShares Nasdaq Biotechnology Index Falls 2.46% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Fri Apr 25, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $223.43 to a high of $229.28. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $223.61 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of iShares Nasdaq Biotechnology Index After 2.46% Loss
Comtex SmarTrend(R) - Fri Apr 25, 3:55PM CDT
iShares Nasdaq Biotechnology Index (AMEX:IBB) traded in a range yesterday that spanned from a low of $223.43 to a high of $229.28. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $223.61 on volume of 2.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Celgene Beats on First-Quarter Earnings: What's Next?
George Budwell, The Motley Fool - Motley Fool - Thu Apr 24, 1:30PM CDT
Source: www.fiercepharma.com. Celgene Corporation    is the second-largest component of the  iShares Nasdaq Biotech Index  . As such, its 14% plus nosedive year to date has undoubtedly played a role in driving this key biotech index lower for...

Earnings from Gilead and Amgen Put These ETFs in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Apr 24, 7:00AM CDT
Solid results from Gilead, but poor results from Amgen, look to have a big impact on these health care ETFs.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 47

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading
Cedars-Sinai and nference Build a Living Data Engine

Updated Category News Views 151

Five million patient histories are not a flashy product demo. They are a serious raw-material advantage, provided the data can be protected, organized, and made useful without turning clinical research into a carnival of loose claims. That is the real weight behind nference's long-term collaboration with Cedars-Sinai, announced November 20, 2026. The pair plan to build a...

Continue Reading
Northgate’s Stanton Opening Puts Community Work First

Updated Category News Views 75

A 55,721-square-foot grocery opening can look like ordinary retail churn until you notice where the money and attention are landing. Northgate González Market’s new Stanton location arrives ahead of Thanksgiving, yes, but the more telling detail is the company’s decision to pair a major store launch with 375 jobs and more than $30,000 directed toward families,...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 102

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 68

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Rosenblatt Book Puts Vegas Casino Blind Spots on Display

Updated Category News Views 143

A locked casino floor is supposed to make secrets expensive. That is why the pitch behind ROSENBLATT lands with a little more weight than the usual Vegas chest-thumping: the coming memoir says Darryl Rosenblatt became a million-dollar gambler while using none of his own money, and that casino operators did not grasp the full shape of what had happened for years. Take a...

Continue Reading
NTN Data Breach Raises Hard Questions Beyond Lawsuit

Updated Category News Views 124

Paperwork lifted from a factory network can become a very expensive loose bolt. NTN Bearing Corporation of America, a U.S. maker of bearings and automotive components, has reported a data-security incident that may have exposed sensitive information belonging to current and former employees. A law firm, Edelson Lechtzin LLP, is investigating potential class-action claims....

Continue Reading
CVS Puts Youth Soccer Stories on Its Store Shelves

Updated Category News Views 60

Two kids with real community ties just got a megaphone most grown-ups never receive. CVS Pharmacy has named Caroline, 9, of Holmes Beach, Florida, and Zoe, 12, of Los Angeles, as the first grand-prize winners of its Home Team Heroes youth soccer contest. Each player’s selected nonprofit soccer organization will receive a $25,000 grant, while their stories will appear on...

Continue Reading
Digital Diabetes Care Has a Bigger Prize Than Devices

Updated Category News Views 121

A glucose sensor is becoming less a gadget than a running conversation between patient, clinician and software. That shift matters because diabetes management is leaving the occasional clinic visit and moving into daily life, where the useful product is not merely a reading but a pattern someone can act on. The sector deserves attention from investors, but it also...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading

Top 5 Most Recently Viewed Articles

Yonder Media Mobile Takes Legal Action Against FuboTV

Updated Category News Views 146

Yonder Media Mobile Initiates Lawsuit Against FuboTV In a recent announcement, Yonder Media Mobile Inc. ("YMM") has taken significant legal action against FuboTV, Inc. ("FuboTV"). This lawsuit contends that FuboTV has engaged in deceptive practices, causing substantial harm to YMM over an extended period. Serious Allegations of Misconduct The heart of the lawsuit revolves...

Continue Reading
United Airlines Stock Dive: It's Crazy but Predictable

Updated Category News Views 243

What's Happening With United Airlines Stock? So, here's the scoop: United Airlines Holdings, Inc. (NASDAQ:UAL) is trying to claw back into the green after a rough patch, you know? Just yesterday, it took a dive—down almost 6%—all thanks to those pesky rising fuel costs. Crude oil prices are hitting six-month highs again, and yeah, that's got investors sweating over...

Continue Reading
Fingerprint Cards' Management Boosts Confidence with New Investments

Updated Category News Views 136

Management's Bold Move in the Rights Issue Fingerprint Cards AB (publ) has taken a significant step in demonstrating their confidence in the company’s future. The CEO and CFO have decided to invest an impressive SEK 2 million in the ongoing rights issue without utilizing unit rights. This decision coincides with the company's efforts to raise approximately SEK 159.9...

Continue Reading
Investigation Launched for Aehr Test Systems, Inc. Investors

Updated Category News Views 200

Investigation for Aehr Test Systems, Inc. Investors Glancy Prongay & Murray LLP, a prominent national law firm specializing in shareholder rights, has officially commenced an investigation into Aehr Test Systems, Inc. (NASDAQ: AEHR) on behalf of investors. This initiative aims to scrutinize potential violations of federal securities laws by the company. Why the...

Continue Reading
Exciting Dual Reward Campaign by AB DAO and Bitget Unveiled

Updated Category News Views 180

AB DAO and Bitget Join Forces for a Rewarding Initiative AB DAO is thrilled to reveal its newest collaboration with Bitget, a prominent name in the digital asset trading sphere. This partnership has led to the creation of a dual reward campaign, aimed at boosting user engagement and enhancing the overall ecosystem. The campaign will distribute a staggering total of...

Continue Reading